A detailed history of Putnam Investments LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 6,270,413 shares of INVA stock, worth $126 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
6,270,413
Previous 6,261,458 0.14%
Holding current value
$126 Million
Previous $81.3 Million 23.66%
% of portfolio
0.14%
Previous 0.13%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$12.32 - $16.27 $110,325 - $145,697
8,955 Added 0.14%
6,270,413 $101 Million
Q3 2023

Nov 14, 2023

SELL
$12.37 - $13.89 $848,173 - $952,395
-68,567 Reduced 1.08%
6,261,458 $81.3 Million
Q2 2023

Aug 14, 2023

BUY
$11.39 - $13.72 $3.67 Million - $4.42 Million
321,843 Added 5.36%
6,330,025 $80.6 Million
Q1 2023

May 22, 2023

BUY
$10.73 - $13.6 $10.8 Million - $13.7 Million
1,007,330 Added 20.14%
6,008,182 $67.6 Million
Q4 2022

Feb 14, 2023

BUY
$11.8 - $13.78 $580,359 - $677,741
49,183 Added 0.99%
5,000,852 $66.3 Million
Q3 2022

Nov 14, 2022

BUY
$11.61 - $15.22 $14.3 Million - $18.8 Million
1,235,940 Added 33.26%
4,951,669 $57.5 Million
Q2 2022

Aug 15, 2022

BUY
$14.32 - $19.88 $14.3 Million - $19.8 Million
995,500 Added 36.6%
3,715,729 $54.8 Million
Q1 2022

May 16, 2022

BUY
$15.39 - $20.25 $11.3 Million - $14.9 Million
736,200 Added 37.11%
2,720,229 $52.6 Million
Q4 2021

Feb 14, 2022

SELL
$15.91 - $18.72 $19 Million - $22.3 Million
-1,192,451 Reduced 37.54%
1,984,029 $34.2 Million
Q3 2021

Nov 15, 2021

SELL
$13.06 - $17.24 $1.68 Million - $2.22 Million
-128,520 Reduced 3.89%
3,176,480 $53.1 Million
Q2 2021

Aug 16, 2021

BUY
$11.45 - $13.96 $17.5 Million - $21.4 Million
1,530,278 Added 86.23%
3,305,000 $44.3 Million
Q1 2021

May 17, 2021

BUY
$11.06 - $12.87 $3.76 Million - $4.38 Million
340,227 Added 23.72%
1,774,722 $21.2 Million
Q4 2020

Feb 16, 2021

BUY
$9.33 - $12.48 $13.4 Million - $17.9 Million
1,434,495 New
1,434,495 $17.8 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.4B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.